ResMed reported $372.79M in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Ansell ANN:AU $ 156.61M 28.59M
Cochlear COH:AU $ 223M 60.1M
Estia Health EHE:AU $ 11.75M 20M
Fisher & Paykel Healthcare FPH:AU 188.37M 114.03M
Healius Ltd HLS:AU $ 373.5M 260M
Integral Diagnostics Ltd IDX:AU 14.54M 4.07M
Japara Healthcare JHC:AU -15896000 2.75M
Mayne Pharma MYX:AU $ -17413000 18.81M
Nanosonics Ltd NAN:AU $ 3.83M 4.71M
Opthea Ltd OPT:AU -54280408.54 33.47M
Polynovo Ltd PNV:AU 1.78M 4.09M
Ramsay Health Care RHC:AU $ 309.7M 42.5M
Regis Healthcare REG:AU 35.01M 7.65M
ResMed RMD:AU $ 372.79M 138.52M
Sigma Healthcare Ltd SIG:AU 8.42M 225K
Sonic Healthcare SHL:AU $ 1.21B 277.93M
Telix Pharmaceuticals Ltd TLX:AU -46919000 16.89M